| 摘要 |
<p>The present invention is based on the discovery that selectively removing N-linked glycans within the amino-terminal portion of a recombinant gp120 glycoprotein of immunodeficiency viruses such as human immunodeficiency type I or simian immunodeficiency virus produces a selectively underglycosylated envelope glycoprotein capable of enhanced antibody responses.</p> |
